Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 févr. 2010 16h05 HE | Source: Questcor Pharmaceuticals

Questcor Announces Fourth Quarter 2009 Earnings Release Date and Conference Call

UNION CITY, Calif., Feb. 11, 2010 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the fourth quarter ended December 31, 2009...
04 févr. 2010 06h30 HE | Source: Questcor Pharmaceuticals

Questcor Appoints Jason Zielonka, M.D. Chief Medical Officer

UNION CITY, Calif., Feb. 4, 2010 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that Jason Zielonka, M.D., (61), has been appointed to the position of Chief Medical...
24 déc. 2009 06h30 HE | Source: Questcor Pharmaceuticals

FDA Accepts for Review Questcor's Filing of Its Supplemental New Drug Application for H.P. Acthar(R) Gel for Treatment of Infantile Spasms

UNION CITY, Calif., Dec. 24, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced the U.S. Food & Drug Administration (FDA) now considers that Questcor has...
11 déc. 2009 06h00 HE | Source: Questcor Pharmaceuticals

Louis Silverman Appointed to Questcor Board of Directors

UNION CITY, Calif., Dec. 11, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that Louis E. Silverman has been appointed to its Board of Directors. Mr. Silverman,...
02 nov. 2009 16h05 HE | Source: Questcor Pharmaceuticals

Questcor Announces Third Quarter 2009 Results

Sales for the treatment of multiple sclerosis up 14% sequentially Sales for the treatment of infantile spasms down 26% sequentially Delayed state Medicaid claims hurt net sales and earnings ...
27 oct. 2009 06h30 HE | Source: Questcor Pharmaceuticals

Questcor to Present at the 20th Annual Oppenheimer Healthcare Conference in New York

UNION CITY, Calif., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the 20th Annual Oppenheimer Healthcare Conference on...
26 oct. 2009 12h15 HE | Source: Questcor Pharmaceuticals

Questcor Issues Corrected Dial-in Numbers for November 2nd Quarterly Conference Call

UNION CITY, Calif., Oct. 26, 2009 (GLOBE NEWSWIRE) -- In the news release, "Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call," issued on October 23, 2009 by Questcor...
23 oct. 2009 06h30 HE | Source: Questcor Pharmaceuticals

Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call

UNION CITY, Calif., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the third quarter ended September 30, 2009...
22 oct. 2009 16h05 HE | Source: Questcor Pharmaceuticals

Questcor Implements Two Corporate Governance Actions

UNION CITY, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that its Board of Directors has unanimously approved two corporate governance matters...
22 oct. 2009 06h30 HE | Source: Questcor Pharmaceuticals

Questcor Expands Management Team

UNION CITY, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that David Young, Pharm.D., Ph.D., currently a member of Questcor's Board of...

Page suivante